- Report
- August 2022
- 117 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,049GBP
Methsuximide is a central nervous system (CNS) drug used to treat certain types of epilepsy. It is an anticonvulsant that works by decreasing the activity of nerve cells in the brain. It is usually prescribed as an adjunct to other anticonvulsants, and is not recommended as a first-line treatment. Common side effects include drowsiness, dizziness, and nausea.
Methsuximide is available in both generic and brand-name formulations. It is typically taken orally, and is available in tablet, capsule, and liquid forms. It is also available as an intravenous solution.
The methsuximide market is a small but important part of the CNS drug market. It is used to treat a specific type of epilepsy, and is often prescribed in combination with other anticonvulsants. It is available in both generic and brand-name formulations, and is typically taken orally.
Some companies in the methsuximide market include Mylan Pharmaceuticals, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more